Xenotransplant gene editor eGenesis snags transplant expert as CMO; John Tsai, Susanne Schaffert among the hard cuts made at Novartis

Eliezer Katz

The waitlist for an organ transplant in the US exceeds 100,000 people, but the biopharma world has long struggled to find solutions for the demand.

In comes the much-talked-about gene editing field. A Cambridge, MA biotech is attempting to use CRISPR...

Click to view original post